Allakos Inc
NASDAQ:ALLK

Watchlist Manager
Allakos Inc Logo
Allakos Inc
NASDAQ:ALLK
Watchlist
Price: 0.3291 USD -0.06%
Market Cap: 29.7m USD

Relative Value

There is not enough data to reliably calculate the relative value of ALLK.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALLK Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-1
Industry
23.5
Forward
-0.5
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.2
Industry
21.9
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.2
Industry
24.3
vs History
82
vs Industry
75
Median 3Y
0.9
Median 5Y
1.1
Industry
3.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
7
vs Industry
23
Median 3Y
0.2
Median 5Y
-0
Industry
5.9
Forward
0.9
vs History
7
vs Industry
21
Median 3Y
0.2
Median 5Y
-0
Industry
6.2
Forward
1
vs History
9
vs Industry
24
Median 3Y
0.3
Median 5Y
-0
Industry
7.7
vs History
7
vs Industry
19
Median 3Y
0.3
Median 5Y
-0
Industry
6.3
vs History
vs Industry
62
Median 3Y
-1.3
Median 5Y
0.1
Industry
5.6

Multiples Across Competitors

ALLK Competitors Multiples
Allakos Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Allakos Inc
NASDAQ:ALLK
29.5m USD 0 -0.3 0.5 0.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
388.8B USD 6.5 165.6 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172.1B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
145.5B USD 5 17.9 12 12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.2B USD 9.7 30.8 22.6 23.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD 5.6 17.5 16.7 18.9
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.3 33.7 58.1 59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.3 159.1 193
P/S Multiple
Revenue Growth P/S to Growth
US
Allakos Inc
NASDAQ:ALLK
Average P/S: 3 383 983
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 837 682.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.7
10%
1
US
E
Epizyme Inc
F:EPE
2 082
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.3
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16
46%
0.3
P/E Multiple
Earnings Growth PEG
US
Allakos Inc
NASDAQ:ALLK
Average P/E: 186.1
Negative Multiple: -0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
17.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
10%
1.7
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.3
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Allakos Inc
NASDAQ:ALLK
Average EV/EBITDA: 35
0.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.6
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Allakos Inc
NASDAQ:ALLK
Average EV/EBIT: 40.4
0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
193
N/A N/A